200,000+ products from a single source!
sales@angenechem.com
640290-67-1 | 2-Hydroxy-5-[[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methyl]amino]benzoic acid
CAS No: 640290-67-1 Catalog No: AG003AKS MDL No:
Product Description
Catalog Number:
AG003AKS
Chemical Name:
2-Hydroxy-5-[[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methyl]amino]benzoic acid
CAS Number:
640290-67-1
Molecular Formula:
C15H8F7NO3
Molecular Weight:
383.2177
IUPAC Name:
2-hydroxy-5-[[2,3,5,6-tetrafluoro-4-(trifluoromethyl)phenyl]methylamino]benzoic acid
InChI:
InChI=1S/C15H8F7NO3/c16-10-7(11(17)13(19)9(12(10)18)15(20,21)22)4-23-5-1-2-8(24)6(3-5)14(25)26/h1-3,23-24H,4H2,(H,25,26)
InChI Key:
HABROHXUHNHQMY-UHFFFAOYSA-N
SMILES:
Fc1c(CNc2ccc(c(c2)C(=O)O)O)c(F)c(c(c1F)C(F)(F)F)F
Properties
Complexity:
490
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
383.039g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
11
Hydrogen Bond Donor Count:
3
Isotope Atom Count:
0
Molecular Weight:
383.222g/mol
Monoisotopic Mass:
383.039g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.4
Literature
| Title | Journal |
|---|---|
| Attenuated effects of Neu2000 on hypoxia-induced synaptic activities in a rat hippocampus. | Archives of pharmacal research 20140201 |
| Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke. | Drug news & perspectives 20101101 |
| The functional and neuroprotective actions of Neu2000, a dual-acting pharmacological agent, in the treatment of acute spinal cord injury. | Journal of neurotrauma 20100101 |
| The novel NMDA receptor antagonist, 2-hydroxy-5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, is a gating modifier in cultured mouse cortical neurons. | Journal of neurochemistry 20090601 |
| Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20070601 |
| Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosis. | Molecular pharmacology 20070401 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.